Published in
Elsevier, The Lancet HIV, 12(9), p. e857-e867, 2022
DOI: 10.1016/s2352-3018(22)00251-x
Links
Tools
Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis
Journal article published in 2022 by
Lise Jamieson,
Leigh F. Johnson 
,
Brooke E. Nichols,
Sinead Delany-Moretlwe,
Mina C. Hosseinipour,
Colin Russell,
Gesine Meyer-Rath
,
Brooke E. Nichols,
Sinead Delany-Moretlwe,
Mina C. Hosseinipour,
Colin Russell,
Gesine Meyer-Rath
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 